GeoVax Labs Inc GOVX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:47 AM EDT
2.39quote price arrow up+0.10 (+4.37%)
Volume
539,015
Close
2.29quote price arrow down-0.03 (-1.29%)
Volume
145,056,437
52 week range
0.55 - 7.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.29
  • 52 Week High7.50
  • 52 Week High Date08/20/21
  • 52 Week Low0.55
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap21.64M
  • Shares Out9.45M
  • 10 Day Average Volume20.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change-36.74

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.29
  • 52 Week High7.50
  • 52 Week High Date08/20/21
  • 52 Week Low0.55
  • 52 Week Low Date05/12/22
  • Market Cap21.64M
  • Shares Out9.45M
  • 10 Day Average Volume20.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change-36.74

RATIOS/PROFITABILITY

  • EPS (TTM)-3.01
  • P/E (TTM)-0.76
  • Fwd P/E (NTM)-2.25
  • EBITDA (TTM)-19.564M
  • ROE (TTM)-121.74%
  • Revenue (TTM)360,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,449.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GeoVax Labs Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GeoVax Labs, Inc. is a clinical-stage biotechnology company. The Company is focused on developing human vaccines and immunotherapies against infectious diseases and cancer using its platforms. Its product pipeline includes ongoing human clinical trials for COVID-19 and head and neck cancer. The Company is developing a number of vaccines and immunotherapies for prevention or treatment of infectious diseases and cancers. The Company’s product candidate includes GEO-CM04S1...
David Dodd
Chairman of the Board, President, Chief Executive Officer
Mark Reynolds CPA
Chief Financial Officer, Corporate Secretary
Address
1900 Lake Park Drive, Suite 380
Smyrna, GA
30080
United States

Top Peers

SYMBOLLASTCHG%CHG
CLSN
Celsion Corp
2.35-0.01-0.42%
BLCM
Bellicum Pharmaceuticals Inc
1.42+0.07+5.19%
GNCA
Genocea Biosciences Inc
0.0609-0.1621-72.6906%
NRBO
Neurobo Pharmaceuticals Inc
0.507-0.0072-1.4002%
CYCC
Cyclacel Pharmaceuticals Inc
1.28-0.07-5.05%